2024
Evolution of Virtual Surgical Planning Use Among Craniofacial Surgeons
Moscarelli J, Hu K, Alper D, Rancu A, Salib A, Ihnat J, Parikh N, Persing J, Alperovich M. Evolution of Virtual Surgical Planning Use Among Craniofacial Surgeons. Journal Of Craniofacial Surgery 2024, 35: 1612-1615. PMID: 38949496, DOI: 10.1097/scs.0000000000010429.Peer-Reviewed Original ResearchVirtual surgical planningAmerican Society of Maxillofacial SurgeonsCraniofacial surgeonsImprove esthetic outcomesRespondents' current practiceShorter operating timeCraniofacial surgery fellowshipPlastic surgery trainingPostablative reconstructionOrthognathic surgeryEsthetic outcomeMaxillofacial surgeonsCraniofacial surgerySurgeon demographicsProcedure typeSurgical planningOperative timeSurgeon's practiceFellowship trainingFacial feminizationSurgeonsSurgery trainingSurgeryContinuous variablesSurgical training
2023
Tranexamic Acid in Facial Feminization Surgery: Quantifying a High-risk Setting With Exogenous Estrogen Supplementation
Alper D, Almeida M, Rivera J, Hosseini H, Williams M, Long A, Prassinos A, Mookerjee V, Persing J, Alperovich M. Tranexamic Acid in Facial Feminization Surgery: Quantifying a High-risk Setting With Exogenous Estrogen Supplementation. Journal Of Craniofacial Surgery 2023, 34: 1452-1455. PMID: 37277900, DOI: 10.1097/scs.0000000000009415.Peer-Reviewed Original ResearchConceptsVenous thromboembolic eventsSafety of TXAExogenous estrogen supplementationTranexamic acidEstrogen supplementationFacial feminization surgeryCaprini scoreVTE ratesBlood lossOperative timeFeminization surgeryHigh-risk patient populationIntraoperative tranexamic acidRisk patient populationHigh-risk settingsUnpaired t-testEstrogen therapyThromboembolic eventsRetrospective reviewHematoma rateProthrombotic agentsPatient populationProcedure typeMedical CenterElevated risk